- Home
- RXT vs CMPX Comparison
RXT vs CMPX Comparison
Compare RXT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- CMPX
- Stock Information
- Founded
- RXT 1998
- CMPX 2014
- Country
- RXT United States
- CMPX United States
- Employees
- RXT N/A
- CMPX N/A
- Industry
- RXT EDP Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- CMPX Health Care
- Exchange
- RXT Nasdaq
- CMPX Nasdaq
- Market Cap
- RXT 274.9M
- CMPX 291.8M
- IPO Year
- RXT 2020
- CMPX N/A
- Fundamental
- Price
- RXT $1.17
- CMPX $2.97
- Analyst Decision
- RXT Hold
- CMPX Strong Buy
- Analyst Count
- RXT 5
- CMPX 8
- Target Price
- RXT $1.58
- CMPX $13.50
- AVG Volume (30 Days)
- RXT 824.1K
- CMPX 1.3M
- Earning Date
- RXT 08-07-2025
- CMPX 08-11-2025
- Dividend Yield
- RXT N/A
- CMPX N/A
- EPS Growth
- RXT N/A
- CMPX N/A
- EPS
- RXT N/A
- CMPX N/A
- Revenue
- RXT $2,693,100,000.00
- CMPX N/A
- Revenue This Year
- RXT N/A
- CMPX N/A
- Revenue Next Year
- RXT $1.48
- CMPX N/A
- P/E Ratio
- RXT N/A
- CMPX N/A
- Revenue Growth
- RXT N/A
- CMPX N/A
- 52 Week Low
- RXT $1.00
- CMPX $1.15
- 52 Week High
- RXT $3.41
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- RXT 42.17
- CMPX 50.84
- Support Level
- RXT $1.12
- CMPX $2.66
- Resistance Level
- RXT $1.30
- CMPX $3.47
- Average True Range (ATR)
- RXT 0.08
- CMPX 0.25
- MACD
- RXT -0.01
- CMPX -0.02
- Stochastic Oscillator
- RXT 22.73
- CMPX 38.27
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.